Literature DB >> 18799951

Postural changes in blood pressure in the general population of Cantabria (northern Spain).

Luis Vara-González1, Pedro Muñoz-Cacho, Saturnino Sanz de Castro.   

Abstract

OBJECTIVE: To describe the postural changes in blood pressure and correlates among the general population of Cantabria, a region in the north of Spain.
METHODS: Between 2002 and 2004 blood pressure measurements were taken in a seated position and after 1 and 3 min standing on a random sample of 1178 individuals aged 18 years and above, stratified by age and sex.
RESULTS: The prevalence of orthostatic hypotension was 7%, whereas 30% of the participants presented an exaggerated increase in blood pressure when standing and 36% presented one of the two alterations (postural dysregulation in blood pressure syndrome). Sixteen percent of the nonhypertensive participants presented a blood pressure figure when standing that was above or equal to 140/90 mmHg (orthostatic hypertension). In logistic regression analysis the existence of a high level of blood pressure when sitting was the only variable related to orthostatic hypotension (odds ratio: 2.407; confidence interval: 1.413-4.099).
CONCLUSION: When evaluating and treating hypertensive patients, it should be taken into account that orthostatic hypotension is more frequent among those individuals who present poor levels of control of their blood pressure figures. Postural dysregulation in blood pressure syndrome is frequent among the general population, and therefore it is worthy of detailed study.

Entities:  

Mesh:

Year:  2008        PMID: 18799951     DOI: 10.1097/MBP.0b013e32830d4b33

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  1 in total

1.  Detecting Risk Of Postural hypotension (DROP): derivation and validation of a prediction score for primary care.

Authors:  Christopher Elles Clark; Daniel Thomas; Fiona C Warren; David J Llewellyn; Luigi Ferrucci; John L Campbell
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.